Home Other Building Blocks Ro20-1724

Ro20-1724

CAS No.:
29925-17-5
Catalog Number:
AG01E42L
Molecular Formula:
C15H22N2O3
Molecular Weight:
278.3468
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
10mg
>98%
1 week
United States
$75
- +
25mg
≥95%
1 week
United States
$91
- +
50mg
≥95%
1 week
United States
$112
- +
100mg
≥95%
1 week
United States
$154
- +
Product Description
Catalog Number:
AG01E42L
Chemical Name:
Ro20-1724
CAS Number:
29925-17-5
Molecular Formula:
C15H22N2O3
Molecular Weight:
278.3468
MDL Number:
MFCD00077397
IUPAC Name:
4-[(3-butoxy-4-methoxyphenyl)methyl]imidazolidin-2-one
InChI:
InChI=1S/C15H22N2O3/c1-3-4-7-20-14-9-11(5-6-13(14)19-2)8-12-10-16-15(18)17-12/h5-6,9,12H,3-4,7-8,10H2,1-2H3,(H2,16,17,18)
InChI Key:
PDMUULPVBYQBBK-UHFFFAOYSA-N
SMILES:
CCCCOc1cc(ccc1OC)CC1CNC(=O)N1
Properties
Complexity:
312  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
278.163g/mol
Formal Charge:
0
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
278.352g/mol
Monoisotopic Mass:
278.163g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
59.6A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
2.4  
Literature
Title Journal
Evaluating the significance of cyclic adenosine monophosphate-mediated signaling in human prostate: a functional and biochemical study. Urology 20121001
Neuroprotective effect of RO-20-1724-a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in rats. Pharmacology, biochemistry, and behavior 20120401
Linalool from rosewood (Aniba rosaeodora Ducke) oil inhibits adenylate cyclase in the retina, contributing to understanding its biological activity. Phytotherapy research : PTR 20120101
Hesperetin, a Selective Phosphodiesterase 4 Inhibitor, Effectively Suppresses Ovalbumin-Induced Airway Hyperresponsiveness without Influencing Xylazine/Ketamine-Induced Anesthesia. Evidence-based complementary and alternative medicine : eCAM 20120101
Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness. Journal of medicinal chemistry 20111208
Inhibition of phosphodiesterase-4 decreases ethanol intake in mice. Psychopharmacology 20111101
Effect of phoshpodiesterase 4 (PDE4) inhibibtors on eotaxin expression in humen bronchial epithelial cells. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20110601
S-Petasin, the Main Sesquiterpene of Petasites formosanus, Inhibits Phosphodiesterase Activity and Suppresses Ovalbumin-Induced Airway Hyperresponsiveness. Evidence-based complementary and alternative medicine : eCAM 20110101
Biochanin a, a phytoestrogenic isoflavone with selective inhibition of phosphodiesterase 4, suppresses ovalbumin-induced airway hyperresponsiveness. Evidence-based complementary and alternative medicine : eCAM 20110101
Hesperetin-7,3'-O-dimethylether selectively inhibits phosphodiesterase 4 and effectively suppresses ovalbumin-induced airway hyperresponsiveness with a high therapeutic ratio. Journal of biomedical science 20110101
Exposure of human seminal vesicle tissue to phosphodiesterase (PDE) inhibitors antagonizes the contraction induced by norepinephrine and increases production of cyclic nucleotides. Urology 20101201
Regulation of 3',5'-cAMP in preglomerular smooth muscle and endothelial cells from genetically hypertensive rats. Hypertension (Dallas, Tex. : 1979) 20101201
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Acute stress impairs hippocampal mossy fiber-CA3 long-term potentiation by enhancing cAMP-specific phosphodiesterase 4 activity. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100601
Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on beta-adrenergic cAMP signals. Circulation research 20091009
Regulation of renovascular adenosine 3',5'-cyclic monophosphate in spontaneously hypertensive rats. Hypertension (Dallas, Tex. : 1979) 20090801
Endothelin downregulates SERCA2 gene and protein expression in adult rat ventricular myocytes: regulation by pertussis toxin-sensitive Gi protein and cAMP. American journal of physiology. Heart and circulatory physiology 20090301
Intravenously administered phosphodiesterase 4 inhibitors dilate retinal blood vessels in rats. European journal of pharmacology 20090105
Adrenomedullin-induced relaxation of rat brain pericytes is related to the reduced phosphorylation of myosin light chain through the cAMP/PKA signaling pathway. Neuroscience letters 20090102
Selective phosphodiesterase inhibitors: a promising target for cognition enhancement. Psychopharmacology 20090101
Inhibition of phosphodiesterase has an additive effect on estrogen's ability to inhibit collagen synthesis in vascular smooth muscle cells. Vascular pharmacology 20090101
Impact of anti-inflammatory agents on the gene expression profile of stimulated human neutrophils: unraveling endogenous resolution pathways. PloS one 20090101
Antipsychotic-like properties of phosphodiesterase 4 inhibitors: evaluation of 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with auditory event-related potentials and prepulse inhibition of startle. The Journal of pharmacology and experimental therapeutics 20080701
Spatiotemporal dynamics of beta-adrenergic cAMP signals and L-type Ca2+ channel regulation in adult rat ventricular myocytes: role of phosphodiesterases. Circulation research 20080509
Effect of cyclic AMP on barrier function of human lymphatic microvascular tubes. Microvascular research 20080501
Numerous distinct PKA-, or EPAC-based, signalling complexes allow selective phosphodiesterase 3 and phosphodiesterase 4 coordination of cell adhesion. Cellular signalling 20071201
Autoregulation in PC12 cells via P2Y receptors: Evidence for non-exocytotic nucleotide release from neuroendocrine cells. Purinergic signalling 20070901
Differential regulation of synaptic transmission by adrenergic agonists via protein kinase A and protein kinase C in layer V pyramidal neurons of rat cerebral cortex. Neuroscience 20070608
Dual regulation of the ATP-sensitive potassium channel by caffeine. American journal of physiology. Cell physiology 20070601
The effect of oxidative stress on macrophages and lung epithelial cells: the role of phosphodiesterases 1 and 4. Toxicology letters 20070110
Ca(2+)-dependent K(+) currents and spike-frequency adaptation in medial entorhinal cortex layer II stellate cells. Hippocampus 20070101
Chronic ethanol feeding suppresses beta-adrenergic receptor-stimulated lipolysis in adipocytes isolated from epididymal fat. Endocrinology 20060901
Characteristics of taurine release in slices from adult and developing mouse brain stem. Amino acids 20060701
Inhibition of PGI2 signaling by miconazole in vascular smooth muscle cells. Prostaglandins & other lipid mediators 20060701
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Role of PDE3B in insulin-induced glucose uptake, GLUT-4 translocation and lipogenesis in primary rat adipocytes. Cellular signalling 20060301
Phosphodiesterase IV and neutral endopeptidase in airways from developing and allergen sensitized rabbits. Pulmonary pharmacology & therapeutics 20060101
Effects of various selective phosphodiesterase inhibitors on carbachol-induced contraction and cyclic nucleotide contents in the guinea pig gall bladder. The Journal of veterinary medical science 20050701
Role of the adenosine 3',5'-cyclic monophosphate (cAMP) in enhancing the efficacy of siRNA-mediated gene silencing in neuroblastoma cells. Oncogene 20050609
Identification and characterization of PDE4A11, a novel, widely expressed long isoform encoded by the human PDE4A cAMP phosphodiesterase gene. Molecular pharmacology 20050601
Inhibition of mast cell histamine release by specific phosphodiesterase inhibitors. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20050401
NSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives. European journal of pharmacology 20050131
Autoinhibition of transmitter release from PC12 cells and sympathetic neurons through a P2Y receptor-mediated inhibition of voltage-gated Ca2+ channels. The European journal of neuroscience 20041201
Phosphodiesterase type IV inhibitors prevent ischemia-reperfusion-induced gastric injury in rats. Journal of pharmacological sciences 20040701
Phosphodiesterase-linked inhibition of nonmicturition activity in the isolated bladder. BJU international 20040601
Sensitivity of proteasome to its inhibitors increases during cAMP-induced differentiation of neuroblastoma cells in culture and causes decreased viability. Cancer letters 20040210
The effect of selective phosphodiesterase inhibitors, alone and in combination, on a murine model of allergic asthma. Respiratory research 20040101
Group II metabotropic glutamate receptor modulation of excitatory transmission in rat subthalamic nucleus. The Journal of physiology 20031201
Effects of phosphodiesterase inhibitors on spontaneous nuclear maturation and cAMP concentrations in bovine oocytes. Theriogenology 20031201
Role of cyclic nucleotide phosphodiesterase isoforms in cAMP compartmentation following beta2-adrenergic stimulation of ICa,L in frog ventricular myocytes. The Journal of physiology 20030815
The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030701
Type IV phosphodiesterase inhibition improves cardiac contractility in endotoxemic rats. European journal of pharmacology 20030328
5-HT7 receptor-mediated relaxation of the oviduct in nonpregnant proestrus pigs. European journal of pharmacology 20030214
Norepinephrine induces slow calcium signalling in murine brown preadipocytes through the beta-adrenoceptor/cAMP/protein kinase A pathway. Cellular signalling 20030201
Lipopolysaccharide-induced acute renal failure in conscious rats: effects of specific phosphodiesterase type 3 and 4 inhibition. The Journal of pharmacology and experimental therapeutics 20021001
Subtype-specific roles of cAMP phosphodiesterases in regulation of atrial natriuretic peptide release. European journal of pharmacology 20020920
Inducible expression of the gap junction protein connexin43 decreases the neoplastic potential of HT-1080 human fibrosarcoma cells in vitro and in vivo. Molecular carcinogenesis 20020901
Regulation of glypican-1, syndecan-1 and syndecan-4 mRNAs expression by follicle-stimulating hormone, cAMP increase and calcium influx during rat Sertoli cell development. European journal of biochemistry 20020701
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. The Journal of biological chemistry 20020419
Altered phosphodiesterase 3-mediated cAMP hydrolysis contributes to a hypermotile phenotype in obese JCR:LA-cp rat aortic vascular smooth muscle cells: implications for diabetes-associated cardiovascular disease. Diabetes 20020401
Occupancy of adenosine A2a receptors promotes fMLP-induced cyclic AMP accumulation in human neutrophils: impact on phospholipase D activity and recruitment of small GTPases to membranes. Journal of leukocyte biology 20020201
Nucleotide-evoked relaxation of rat vas deferens: possible mechanisms. European journal of pharmacology 20020201
Caffeine eliminates gamma-ray-induced G2-phase delay in human tumor cells but not in normal cells. Radiation research 20020101
Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells. British journal of pharmacology 20010901
Role of cyclic nucleotides in vasodilations of the rat thoracic aorta induced by adenosine analogues. British journal of pharmacology 20010701
17beta-estradiol modulates prostaglandin E2 release from human amnion-derived wish cells. Biology of reproduction 20010601
Modulation of excitability in Aplysia tail sensory neurons by tyrosine kinases. Journal of neurophysiology 20010601
Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouse. Biochimica et biophysica acta 20010319
Phthalic acid mimics 17beta-estradiol actions in WISH cells. Toxicology letters 20010103
Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine. The Journal of pharmacology and experimental therapeutics 20010101
[Inhibition of uterine contractions: new in vitro pharmacological approaches on the pregnant human myometrium]. Therapie 20010101
Phosphodiesterase type 4 inhibitors, but not glucocorticoids, are more potent in suppression of cytokine secretion by mononuclear cells from atopic than nonatopic donors. The Journal of allergy and clinical immunology 19981101
Decreased presynaptic sensitivity to adenosine after cocaine withdrawal. The Journal of neuroscience : the official journal of the Society for Neuroscience 19981001
Beta-adrenergic regulation of renin expression in differentiated U-937 monocytic cells. Biochemical pharmacology 19970615
Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D. Biochemical and biophysical research communications 19970519
Differential modulation of cytokine production by drugs: implications for therapy in heart failure. Journal of molecular and cellular cardiology 19961201
Dipyridamole enhances interleukin-1beta-stimulated nitric oxide production by cultured rat vascular smooth muscle cells. European journal of pharmacology 19960205
Inhibition of ornithine decarboxylase and S-adenosylmethionine decarboxylase activities of S49 lymphoma cells by agents increasing cyclic AMP. Journal of cyclic nucleotide research 19810101
Properties